Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?
Abstract
BACKGROUND: The goal of this study was to prospectively analyze the diagnostic performances of magnetic resonance imaging (MRI) and positron emission tomography (PET)/computed tomography (CT) in predicting pathologically assessed residual disease in a large, single‐institution series of locally advanced cervical cancer (LACC) patients triaged to neoadjuvant treatments followed by radical surgery.METHODS: Between April 2007 and March 2010, 96 patients with histologically documented cervical cancer (any histology) and FIGO stage IB2‐IVA were enrolled. MRI and PET/CT were recommended to be performed within 4‐6 weeks from the end of treatment, and histology was the reference standard. Sensitivity, specificity, and accuracy were compared using the McNemar test.RESULTS: For residual disease in the cervix, sensitivity was higher for MRI than for PET/CT (86.1% vs 63.1%; P = .002), while specificity was significantly higher for PET/CT compared with MRI (P = .002). There was no difference in accuracy values between the 2 imaging modalities. For MRI analysis of lymph node groups, sensitivity, specificity, and accuracy were 35.7%, 95.9%, and 88.0%, respectively. Conversely, sensitivity, specificity, and accuracy for PET/CT were 28.6%, 97.8%, and 88.7%, respectively. Absence of follicular structures replaced by prevalent sclerosis and/or sinus histiocytosis was the most frequently documented morphological pattern in false‐positive cases.CONCLUSION: Neither MRI nor PET/CT accurately detected residual disease in LACC patients triaged to radical surgery after neoadjuvant treatment, disallowing the option of avoiding or modulating completion surgery. Cancer 2011;. © 2011 American Cancer Society.Keywords
This publication has 28 references indexed in Scilit:
- Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancerAmerican Journal of Obstetrics and Gynecology, 2010
- Surgical and radiologic staging of cervical cancerCurrent Opinion in Obstetrics and Gynecology, 2010
- PET/CT Imaging to Guide Cervical Cancer TherapyFuture Oncology, 2009
- MRI and PET/CT for Triaging Stage IB Clinically Operable Cervical Cancer to Appropriate Therapy: Decision Analysis to Assess Patient OutcomesAmerican Journal of Roentgenology, 2009
- Surveillance FDG-PET detection of asymptomatic recurrences in patients with cervical cancerGynecologic Oncology, 2009
- 18-F-Fluorodeoxyglucose–Positron Emission Tomography Evaluation of Early Metabolic Response During Radiation Therapy for Cervical CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Association of Posttherapy Positron Emission Tomography With Tumor Response and Survival in Cervical CarcinomaJAMA, 2007
- Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinomaCancer, 2006
- The SMART scanner: a combined PET/CT tomograph for clinical oncology2002
- A comparison of MRI and PET scanning in surgically staged loco-regionally advanced cervical cancer: Potential impact on treatmentInternational Journal of Gynecological Cancer, 2001